HG Remold

585 total citations
10 papers, 506 citations indexed

About

HG Remold is a scholar working on Immunology, Cancer Research and Hematology. According to data from OpenAlex, HG Remold has authored 10 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 5 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in HG Remold's work include Protease and Inhibitor Mechanisms (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Macrophage Migration Inhibitory Factor (3 papers). HG Remold is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Macrophage Migration Inhibitory Factor (3 papers). HG Remold collaborates with scholars based in United States and Austria. HG Remold's co-authors include Johannes C. Kirchheimer, W Y Weiser, Patricia A. Temple, J Witek-Giannotti, S C Clark, John R. David, Philip L. McCarthy, DW Golde, Dávid and Sheldon C. Engelhorn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

HG Remold

10 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
HG Remold United States	6	296	194	128	105	82	10	506
Piao Lo United States	6	149 0.5×	109 0.6×	53 0.4×	18 0.2×	269 3.3×	7	537
SF Ziegler United States	10	393 1.3×	59 0.3×	75 0.6×	16 0.2×	135 1.6×	13	605
R Basu United States	7	153 0.5×	19 0.1×	80 0.6×	54 0.5×	237 2.9×	8	427
Cornelia Escher Germany	7	231 0.8×	153 0.8×	26 0.2×	21 0.2×	336 4.1×	7	542
Tomoko Iguchi Japan	10	288 1.0×	16 0.1×	91 0.7×	149 1.4×	284 3.5×	14	655
Helle H. Petersen Denmark	10	47 0.2×	249 1.3×	148 1.2×	12 0.1×	189 2.3×	11	401
Theresa Seaton United States	3	69 0.2×	70 0.4×	28 0.2×	10 0.1×	95 1.2×	5	277
Tammy P. Cheng United States	12	284 1.0×	36 0.2×	43 0.3×	11 0.1×	135 1.6×	12	521
Christina Lutz‐Nicoladoni Austria	11	287 1.0×	58 0.3×	24 0.2×	18 0.2×	263 3.2×	14	543
Simon Fry United Kingdom	7	101 0.3×	140 0.7×	49 0.4×	8 0.1×	237 2.9×	7	352

Countries citing papers authored by HG Remold

Since Specialization

Citations

This map shows the geographic impact of HG Remold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HG Remold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HG Remold more than expected).

Fields of papers citing papers by HG Remold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HG Remold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HG Remold. The network helps show where HG Remold may publish in the future.

Co-authorship network of co-authors of HG Remold

This figure shows the co-authorship network connecting the top 25 collaborators of HG Remold. A scholar is included among the top collaborators of HG Remold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HG Remold. HG Remold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Remold, HG, et al.. (1993). Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. Lung Cancer. 8(5-6). 336–336. 5 indexed citations

2.

Kirchheimer, Johannes C., et al.. (1990). Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.. The Journal of Immunology. 145(5). 1518–1522. 33 indexed citations

3.

Engelhorn, Sheldon C., et al.. (1989). Il 4 abrogates the activation of human cultured monocytes by ifn gamma. The FASEB Journal. 3(3). 822. 1 indexed citations

4.

Remold, HG, et al.. (1989). Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 74(4). 1396–1402. 86 indexed citations

5.

Kirchheimer, Johannes C. & HG Remold. (1989). Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes.. The Journal of Immunology. 143(8). 2634–2639. 87 indexed citations

6.

Weiser, W Y, Patricia A. Temple, J Witek-Giannotti, et al.. (1989). Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.. Proceedings of the National Academy of Sciences. 86(19). 7522–7526. 278 indexed citations

7.

Remold, HG, et al.. (1989). Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 74(4). 1396–1402. 7 indexed citations

8.

Golde, DW, et al.. (1986). T cell-derived migration-inhibitory factor and colony-stimulating factor share common structural elements. Blood. 67(6). 1619–1623. 2 indexed citations

9.

Remold, HG, et al.. (1981). Purification of guinea pig pH 3 migration inhibitory factor.. Proceedings of the National Academy of Sciences. 78(7). 4088–4091. 5 indexed citations

10.

Dávid, et al.. (1972). Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.. PubMed. 4(2). 241–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact